Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort: Liver International

A. Soria, M. Fava, D.P. Bernasconi, G. Lapadula, E. Colella, M.G. Valsecchi, G.M. Migliorino, R. D'Ambrosio, S. Landonio, M. Schiavini, A. Spinetti, C. Carriero, E. Degasperi, G. Cologni, F. Gatti, P. Viganò, H. Hasson, C. Uberti-Foppa, L. Pasulo, C. BaigueraR. Rossotti, M. Vinci, M. Puoti, A. Giorgini, B. Menzaghi, A. Lombardi, A. Pan, A. Aghemo, P.A. Grossi, R. Boldizzoni, S. Colombo, M. Viganò, M.G. Rumi, P. Del Poggio, L. Valenti, O. Giglio, A. De Bona, A. d'Arminio Monforte, A. Colombo, O. Spinelli, M.G. Pigozzi, C. Molteni, P. Bonfanti, N. Terreni, P. Perini, A. Capretti, D. Bella, C. Liani, S. Polo, G. Aimo, L. Pagnucco, S. Bhoori, R. Centenaro, M. Graffeo, A. Ciaccio, E. Dionigi, S. Lazzaroni, I. Carderi, M. Di Marco, G. Rizzardini, F. Noventa, P. Lampertico, S. Fagiuoli

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)769-777
Number of pages9
JournalLiver Int.
Volume40
Issue number4
DOIs
Publication statusPublished - 2020

Keywords

  • daclatasvir
  • genotype 3
  • glecaprevir
  • Hepatitis C
  • pibrentasvir
  • ribavirin
  • sofosbuvir
  • sustained virological response
  • velpatasvir
  • daclatasvir plus sofosbuvir
  • glecaprevir plus pibrentasvir
  • sofosbuvir plus velpatasvir
  • unclassified drug
  • virus RNA
  • adult
  • antiviral therapy
  • Article
  • cohort analysis
  • comparative effectiveness
  • female
  • hepatitis C
  • Hepatitis C virus genotype 3
  • human
  • Human immunodeficiency virus infected patient
  • liver cirrhosis
  • longitudinal study
  • major clinical study
  • male
  • multicenter study
  • sex difference
  • sustained virologic response
  • treatment duration
  • treatment response

Cite this